New Natural-Material heart valve could fix tricuspid trouble

NCT ID NCT05742906

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study is testing a new replacement valve for the tricuspid valve, which controls blood flow in the heart. The valve is made from natural materials and is designed to treat tricuspid valve disease in both adults and children. Researchers want to see if the valve can be safely implanted and if it works well for at least 12 months. Participants will have the valve implanted and be followed for up to 5 years.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Cor TRICUSPID ECM Valve (a replacement heart valve made from natural materials)
What this could lead to
If successful, this could provide a safe and effective new option for replacing a diseased tricuspid valve, potentially improving heart function and quality of life.
What could go wrong
This is a pivotal study but still early in testing. The device may not work as expected, and risks include infection, valve failure, or need for additional procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRICUSPID VALVE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Columbia University Irving Medical Center/New York Presbyterian

    RECRUITING

    New York, New York, 10032, United States

  • St Francis Hospital

    RECRUITING

    Indianapolis, Indiana, 46237, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.